Clinical Evaluation of the Efficacy of Safoof-e-Ziabetus- A Polyherbal Unani Formulation in the Management of Ziabetus Shakri (Type 2 Diabetes Mellitus)-A Randomised, Single Blind,Standard Controlled Clinical Trial.

Central Council of Research in Unani Medicine New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•Patients of any gender (Male,Female,Transgender)in the age group of 20-70 yrs of age.
•Fasting Plasma Glucose levels in the range of 126-150 mg/dl.
•Post Prandial Plasma Glucose levels between 200-250 mg/dl.
•Patients having ALT,AST,Sr.Creatinine, Blood Urea with normal limits.
•Patients ready to participate in the study and willing to follow the instructions.

•Patients with Fasting Plasma Glucose level >150 mg/dl
•Postprandial Plasma Glucose level >250 mg/dl
•-Diabetes Mellitus associated with complications of Ketoacidosis
•Diabetes Mellitus Type-I/ Diabetes Insipidus/ Patients on Insulin therapy
•Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
•Pregnant and lactating women
•Complications (microangiopathies) associated with longstanding Diabetes like Diabetic Neuropathy, Diabetic Nephropathy and Diabetic Retinopathy
•Patients having malignancy

发起方

Central Council of Research in Unani Medicine New Delhi